- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
The Danish pharmaceuticals maker is facing tighter margins and tougher competition in the U.S.
Cramers is avoiding Nike and loves Newell so much he bought the company for Action Alerts PLUS.
The stocks we thought would be the strongest in 2016 are now losing their footing, Cramer says.
Eli Lilly (LLY) was upgraded to 'buy' from 'neutral' on Tuesday at Goldman Sachs.